We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The UK's Competition and Markets Authority (CMA) has now formally concluded that three pharmaceutical companies - Aspen, Tiofarma, and Amilco - took part in an illegal arrangement that inflated the price of life-saving medicine fludrocortisone.